文献速递腹部CT

基于术前CT整合形态学与身体成分参数的风险评分预测胃癌根治术后无复发生存的开发与验证

Development and validation of a preoperative CT-based risk score integrating morphological and body composition parameters to predict recurrence-free survival in gastric cancer patients following curative surgery.
PubMed 文献 · Eur J Radiol · 2025-07-16

该回顾性研究纳入2016年6月至2021年6月接受术前CT且经手术确诊的395例胃癌患者(训练集237例、验证集158例),基于肠壁外血管侵犯、Borrmann分型、骨骼肌指数、皮下脂肪密度及淋巴细胞与单核细胞比值构建术前风险评分,训练集C指数0.806(95%CI 0.763-0.849)、验证集0.735(95%CI 0.671-0.798),以最佳截断值28分层低危与高危组。

要点

  • 风险评分由EMVI、Borrmann分型、骨骼肌指数、皮下脂肪密度及LMR五个变量构成。
  • 训练集预测1、2、3年RFS的AUC分别为0.796、0.858、0.893。
  • 以最佳截断值28可将患者分为低危组与高危组,DCA显示临床获益优于AJCC分期。

核心结论

  • 联合CT形态学特征、身体成分参数与临床指标的术前风险评分可有效预测胃癌患者术后无复发生存,有助于术前风险分层和治疗方案选择。

研究设计与样本

  • 回顾性分析2016年6月至2021年6月接受术前CT扫描且经手术确诊的胃癌患者395例,分为训练集237例和验证集158例,采用单因素及多因素Cox回归在训练队列中筛选与术后RFS相关的关键风险因素。

关键影像表现/征象

  • 肠壁外血管侵犯(EMVI)被识别为胃癌术后RFS的独立预测因素。
  • Borrmann分型被识别为胃癌术后RFS的独立预测因素。
  • 骨骼肌指数(SMI)被识别为胃癌术后RFS的独立预测因素。
  • 皮下脂肪密度(SFD)被识别为胃癌术后RFS的独立预测因素。
  • 淋巴细胞与单核细胞比值(LMR)被识别为胃癌术后RFS的独立预测因素。

诊断标准与关键数值

  • 风险评分C指数:训练集0.806(95%CI 0.763-0.849),验证集0.735(95%CI 0.671-0.798)。
  • 训练集预测术后1、2、3年RFS的AUC分别为0.796、0.858、0.893。
  • 验证集预测术后1、2、3年RFS的AUC分别为0.728、0.829、0.862。
  • 以最佳截断值28将患者分为低风险组和高风险组。

临床应用与阅片要点

  • 该评分在多个时间点的预测价值优于AJCC分期和术前指标。
  • DCA曲线显示风险评分相比AJCC分期具有更有利的临床获益。
  • 评分可在术前构建,便于术前风险分层并辅助选择合适治疗方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND OBJECTIVE: Numerous prognostic prediction models for gastric cancer (GC) have been established by utilizing genomics, radiomics, and clinical data. However, most of these models encounter challenges, including lengthy data acquisition, complex operational procedures, and high costs. Moreover, some indicators are obtained post-surgery. This study aims to investigate the prognostic value of CT morphological features and body composition parameters for GC patients, and to construct a simpler and more convenient preoperative risk score in conjunction with clinical indicators to predict recurrence-free survival (RFS) after radical surgery for GC patients.

METHODS: We conducted a retrospective analysis of GC patients who received preoperative CT scans and had their diagnoses surgically confirmed between June 2016 and June 2021. Using univariate and multivariate Cox regression analysis on the training cohort, we identified key risk factors associated with RFS following GC surgery. The predictive performance of the score was evaluated using the C-index, calibration curve, time-dependent receiver operating characteristic (tdROC) curve analysis, and decision curve analysis (DCA) in the training set and validation set. The Kaplan-Meier (KM) survival curves of RFS were plotted based on the risk group and compared using the log-rank test.

RESULTS: The study included 395 patients, divided into a training set of 237 and a validation set of 158. Five variables, extramural vascular invasion (EMVI), Borrmann type, skeletal muscle index (SMI), subcutaneous fat density (SFD), and lymphocyte-to-monocyte ratio (LMR), were identified as independent predictors of RFS in GC patients post-surgery. The calibration curve of the risk score exhibited high consistency, with a C-index of 0.806 (95% CI: 0.763-0.849) in the training set and 0.735 (95% CI: 0.671-0.798) in the validation set. At various time points, the risk score exhibited superior predictive value compared to the American Joint Committee (AJCC) staging and preoperative indicators. In the training set, the area under the curves (AUCs) for predicting 1, 2, and 3-year RFS after GC surgery were 0.796, 0.858, and 0.893, respectively. In the validation set, the AUCs for predicting 1, 2, and 3-year RFS after GC surgery were 0.728, 0.829, and 0.862, respectively. Furthermore, in the DCA curve, the risk score demonstrated more favorable clinical benefit compared to AJCC staging. Based on the optimal cutoff value of 28, the risk score successfully stratified patients into low-risk and high-risk groups.

CONCLUSION: The preoperative risk score, constructed by combining CT morphological features, body composition parameters, and clinical indicators, can effectively predict postoperative RFS in GC patients, thereby facilitating preoperative risk stratification and the selection of appropriate treatment regimens.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Cong R, Ming J, Xu R, et al. Development and validation of a preoperative CT-based risk score integrating morphological and body composition parameters to predict recurrence-free survival in gastric cancer patients following curative surgery. Eur J Radiol. 2025. PMID: 40684710. doi:10.1016/j.ejrad.2025.112318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。